Viewing Study NCT01063803


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2026-05-29 @ 9:38 AM
Study NCT ID: NCT01063803
Status: COMPLETED
Last Update Posted: 2016-04-11
First Post: 2010-02-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis
Sponsor: Ablynx, a Sanofi company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Open-label View
None Long-term safety study of ATN-103 in RA View